adenosine diphosphate ribose has been researched along with nicotinamide-beta-riboside in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alhammad, YMO; Brenner, C; Cohen, MS; Fehr, AR; Heer, CD; Perlman, S; Sanderson, DJ; Schmidt, MS; Trammell, SAJ; Voth, LS | 1 |
1 other study(ies) available for adenosine diphosphate ribose and nicotinamide-beta-riboside
Article | Year |
---|---|
Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
Topics: A549 Cells; Adenosine Diphosphate Ribose; ADP-Ribosylation; Adult; Animals; Cell Line, Tumor; COVID-19; Female; Ferrets; Humans; Immunity, Innate; Male; Metabolome; Mice; Mice, Inbred C57BL; NAD; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridinium Compounds; SARS-CoV-2 | 2020 |